Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 13, 2021

SELL
$10.72 - $22.0 $1.22 Million - $2.5 Million
-113,450 Closed
0 $0
Q4 2020

Feb 12, 2021

BUY
$9.67 - $13.5 $980,412 - $1.37 Million
101,387 Added 840.48%
113,450 $1.25 Million
Q3 2020

Oct 30, 2020

BUY
$8.8 - $14.55 $106,154 - $175,516
12,063 New
12,063 $139,000

Others Institutions Holding AYLA

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0

About Ayala Pharmaceuticals, Inc.


  • Ticker AYLA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 14,833,300
  • Description
  • Ayala Pharmaceuticals, Inc., a clinical-stage oncology company, focuses on developing and commercializing small molecule therapeutics for patients suffering from rare and aggressive cancers. The company's lead product candidate is AL101, a potent, selective, and injectable small molecule gamma secretase inhibitor (GSI) that is in Phase II clinic...
More about AYLA
Track Cathie Wood's Portfolio

Track Cathie Wood Portfolio

Follow Cathie Wood (Ark Investment Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ark Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ark Investment Management LLC and Cathie Wood with notifications on news.